EchoMeasure
Overview
EchoMeasure by iCardio.ai is an FDA 510(k) cleared artificial intelligence software designed to automate and enhance the interpretation of cardiac ultrasound images. It processes previously acquired DICOM-compliant transthoracic cardiac ultrasound images, providing automated view classification, image quality assessment, and precise estimation of numerous cardiac anatomical measurements and quantities.
The software aims to support qualified cardiologists, sonographers, and other licensed professional healthcare practitioners in clinical decision-making, aiding diagnostic review, analysis of echocardiographic data, patient record management, and reporting. By automating standard linear and volumetric measurements, EchoMeasure helps minimize intra-reader variability and improve efficiency and accuracy in echocardiographic analysis.
EchoMeasure integrates seamlessly into existing reporting workflows and can be deployed on a secure cloud server or on-premise server. It features a native browser interface for reviewing report summaries, 2D images, and cine loops, with functionality to download reports in PDF format.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated processing of DICOM-compliant cardiac ultrasound images
- Automated view classification and image quality assessment
- Automated estimation of over a dozen cardiac measurements (linear and volumetric)
- Automated preliminary report generation in PDF format
- Machine learning-based view detection, key frame selection, and segmentation
- Browser interface for reviewing reports, 2D images, and cine loops
- API for seamless integration with third-party software and hardware
- Support for clinical decision-making and diagnostic review
- Tools for organizing and displaying quantitative cardiovascular image data
- Indicated for use in adult patients
Use Cases
- Automating echocardiographic interpretation and preliminary reporting
- Assisting cardiologists and sonographers in clinical decision-making
- Reducing intra-reader variability and improving consistency in echo reads
- Increasing efficiency and accuracy of echocardiographic analysis
- Integration with point-of-care ultrasound (POCUS) devices for enhanced access and quality
- Streamlining patient record management and reporting workflows
What Physicians Need to Know
EchoMeasure can significantly enhance diagnostic efficiency and reduce inter-reader variability in echocardiography by automating numerous measurements and interpretations. Leverage its FDA-cleared capabilities for comprehensive cardiac assessment, particularly for conditions like aortic stenosis and heart failure. The real-time feedback and automated reporting can streamline workflows, allowing more focus on patient interaction and complex clinical decision-making. Consider its integration with existing PACS and monitoring systems to optimize data flow and access.
EchoMeasure offers flexible integration options, including a robust API for seamless connection with various healthcare IT systems. It supports integration with PACS systems and is distributed through partners like GE Healthcare, Viz.ai, UltraLinQ, and Butterfly Network. The platform is available with both cloud-based and on-premises deployment models, ensuring adaptability to different institutional infrastructures. Future integrations include enhancing intracardiac echocardiography capabilities through a partnership with Abbott.
Details
| Category | Cardiology AI |
| Pricing | Paid — Base charge: $6,000-15,000/month; Per scan: $2-4/scan |
| Deployment | Cloud-based; On-premise server |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated iCardio.ai EchoMeasure received U.S. Food and Drug Administration (FDA) 510(k) clearance (K241430) on October 10, 2024. It is cleared as software that processes previously acquired DICOM-compliant cardiac ultrasound images to provide automated estimation of several cardiac measurements and aid diagnostic review and analysis of echocardiographic data, patient record management, and reporting. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology |
What the Web Says
EchoMeasure, developed by iCardio.ai, is an FDA 510(k) cleared AI software designed to automate and enhance echocardiographic analysis. It aims to improve efficiency and accuracy in cardiac measurements, addressing issues like variability in interpretation and the time cardiologists and sonographers spend on repetitive tasks. The software integrates into existing workflows and provides automated estimations for over a dozen linear and volumetric cardiac measurements.
Overall: PositiveStrengths
- Automates over a dozen cardiac measurements, reducing manual effort and potential for work-related musculoskeletal disorders (WRMSDs) for sonographers.
- Demonstrates superiority over human readers in interpreting echocardiography, including ejection fraction estimation.
- FDA 510(k) cleared, indicating it meets regulatory standards for safety and effectiveness.
- Can be seamlessly integrated into standard reporting workflows.
- Aids in diagnostic review and analysis of echocardiographic data, patient record management, and reporting.
- Shows compelling performance in outpatient imaging environments with varying image quality, demonstrating high sensitivity and specificity.
Limitations
- No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra regarding EchoMeasure. The Reddit discussions about 'echo' tests generally focused on the patient experience of the ultrasound itself, rather than the AI software used for interpretation.
Based on reviews from: iCardio.ai, accessdata.fda.gov, MedAxiom, Reddit
Last updated: 2026-07-19
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate EchoMeasure
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for EchoMeasure.
No videos found. Search YouTube directly
